CCDC30
geneOn this page
Also known as FLJ20972PFD6LLOC728621
Summary
CCDC30 (coiled-coil domain containing 30, HGNC:26103) is a protein-coding gene on chromosome 1p34.2, encoding Coiled-coil domain-containing protein 30 (Q5VVM6).
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 352 total — 2 pathogenic, 3 likely-pathogenic
- MANE Select transcript:
NM_001395517
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26103 |
| Approved symbol | CCDC30 |
| Name | coiled-coil domain containing 30 |
| Location | 1p34.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20972, PFD6L, LOC728621 |
| Ensembl gene | ENSG00000186409 |
| Ensembl biotype | protein_coding |
| Entrez | 728621 |
Gene structure
Transcript identifiers
Ensembl transcripts: 56 — 22 protein_coding, 13 protein_coding_CDS_not_defined, 12 nonsense_mediated_decay, 9 retained_intron
ENST00000340612, ENST00000342022, ENST00000462063, ENST00000468651, ENST00000471390, ENST00000471699, ENST00000475614, ENST00000477155, ENST00000492422, ENST00000495044, ENST00000507855, ENST00000509712, ENST00000514642, ENST00000653544, ENST00000653735, ENST00000654604, ENST00000654683, ENST00000655164, ENST00000655265, ENST00000655447, ENST00000655845, ENST00000656306, ENST00000656470, ENST00000657248, ENST00000657597, ENST00000658812, ENST00000660083, ENST00000660830, ENST00000660910, ENST00000660938, ENST00000661864, ENST00000663139, ENST00000663155, ENST00000663866, ENST00000664192, ENST00000664418, ENST00000664805, ENST00000665137, ENST00000665176, ENST00000665217, ENST00000665466, ENST00000665792, ENST00000665812, ENST00000666893, ENST00000667055, ENST00000667205, ENST00000667947, ENST00000668036, ENST00000668663, ENST00000669138, ENST00000669471, ENST00000670292, ENST00000670783, ENST00000670982, ENST00000671281, ENST00000671538
RefSeq mRNA: 10 — MANE Select: NM_001395517
NM_001080850, NM_001355224, NM_001355226, NM_001355227, NM_001395379, NM_001395382, NM_001395383, NM_001395384, NM_001395385, NM_001395517
CCDS: CCDS30690, CCDS90929, CCDS90931
Canonical transcript exons
ENST00000657597 — 21 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003462819 | 42642473 | 42642609 |
| ENSE00003465826 | 42556156 | 42556405 |
| ENSE00003468561 | 42610978 | 42611090 |
| ENSE00003485527 | 42539173 | 42539310 |
| ENSE00003487957 | 42536476 | 42536601 |
| ENSE00003494500 | 42646135 | 42646317 |
| ENSE00003503454 | 42545410 | 42545579 |
| ENSE00003522835 | 42589321 | 42589483 |
| ENSE00003527184 | 42577020 | 42577229 |
| ENSE00003599985 | 42653376 | 42653443 |
| ENSE00003628742 | 42637237 | 42637378 |
| ENSE00003641412 | 42644693 | 42644807 |
| ENSE00003678803 | 42566296 | 42566475 |
| ENSE00003679144 | 42581360 | 42581514 |
| ENSE00003821726 | 42498818 | 42498916 |
| ENSE00003823490 | 42497098 | 42497213 |
| ENSE00003824084 | 42490158 | 42490229 |
| ENSE00003826110 | 42482663 | 42482816 |
| ENSE00003855836 | 42480461 | 42480566 |
| ENSE00003864303 | 42653818 | 42657190 |
| ENSE00003966234 | 42463286 | 42463898 |
Expression profiles
Bgee: expression breadth ubiquitous, 181 present calls, max score 94.52.
FANTOM5 (CAGE): breadth broad, TPM avg 3.9999 / max 172.2434, expressed in 890 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2458 | 3.6550 | 781 |
| 2456 | 0.3449 | 163 |
Top tissues by expression
280 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 94.52 | gold quality |
| sural nerve | UBERON:0015488 | 89.58 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.67 | gold quality |
| sperm | CL:0000019 | 86.85 | silver quality |
| adenohypophysis | UBERON:0002196 | 86.84 | gold quality |
| bronchial epithelial cell | CL:0002328 | 85.57 | gold quality |
| pituitary gland | UBERON:0000007 | 84.74 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.53 | gold quality |
| left testis | UBERON:0004533 | 83.90 | gold quality |
| male germ cell | CL:0000015 | 83.72 | silver quality |
| right testis | UBERON:0004534 | 82.92 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 82.43 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 81.80 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 81.50 | gold quality |
| testis | UBERON:0000473 | 81.48 | gold quality |
| thyroid gland | UBERON:0002046 | 81.36 | gold quality |
| cortical plate | UBERON:0005343 | 80.32 | gold quality |
| ventricular zone | UBERON:0003053 | 80.25 | gold quality |
| bronchus | UBERON:0002185 | 80.05 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.79 | gold quality |
| metanephros cortex | UBERON:0010533 | 79.77 | gold quality |
| buccal mucosa cell | CL:0002336 | 77.59 | silver quality |
| right lung | UBERON:0002167 | 77.35 | gold quality |
| left ovary | UBERON:0002119 | 77.25 | gold quality |
| colonic epithelium | UBERON:0000397 | 76.64 | gold quality |
| caudate nucleus | UBERON:0001873 | 76.44 | gold quality |
| right frontal lobe | UBERON:0002810 | 76.39 | gold quality |
| nucleus accumbens | UBERON:0001882 | 76.19 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 75.97 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.31 |
| E-CURD-135 | no | 1090.19 |
| E-MTAB-2983 | no | 20.78 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- A novel human prefoldin PFD6L from the fetal brain was cloned and characterized. (PMID:16710767)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccdc30 | ENSMUSG00000028637 |
| rattus_norvegicus | Ccdc30 | ENSRNOG00000008560 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 30 — Q5VVM6 (reviewed: Q5VVM6)
Alternative names: Prefoldin subunit 6-like protein
All UniProt accessions (24): Q5VVM6, A0A2U3TZI4, A0A590UJ28, A0A590UJ34, A0A590UJ69, A0A590UJ77, A0A590UJ83, A0A590UJ92, A0A590UJA8, A0A590UJC1, A0A590UJC6, A0A590UJI4, A0A590UJK6, A0A590UJL6, A0A590UJL9, A0A590UJQ0, A0A590UJW7, A0A590UK05, A0A590UK19, A0A590UK35, A0A590UKA3, A0A590UKA6, D6RFH8, F6UBW0
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Expressed in brain, kidney, pancreas, placenta, liver, thymus and prostate.
Similarity. Belongs to the prefoldin subunit beta family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5VVM6-1 | 1 | yes |
| Q5VVM6-2 | 2 |
RefSeq proteins (10): NP_001074319, NP_001342153, NP_001342155, NP_001342156, NP_001382308, NP_001382311, NP_001382312, NP_001382313, NP_001382314, NP_001382446* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031476 | DUF4686 | Family |
| IPR052825 | CCD-Prefoldin_beta-like | Family |
Pfam: PF15742
UniProt features (15 total): region of interest 4, compositionally biased region 3, coiled-coil region 3, splice variant 2, chain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VVM6-F1 | 70.27 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 47 (showing top):
chr1p34, DBP_Q6, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN, BARX1_TARGET_GENES, FOXN3_TARGET_GENES, HOXB6_TARGET_GENES, ZSCAN31_TARGET_GENES, GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2, MIR6739_5P, MIR6733_5P, MIR3153, MIR4779, GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
844 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC30 | WDR64 | B1ANS9 | 617 |
| CCDC30 | ARMH2 | H3BNL8 | 543 |
| CCDC30 | HMGXB4 | Q9UGU5 | 535 |
| CCDC30 | RIMKLA | Q8IXN7 | 527 |
| CCDC30 | ZMYND12 | Q9H0C1 | 447 |
| CCDC30 | BRD7 | Q9NPI1 | 423 |
| CCDC30 | CFAP144 | A6NL82 | 419 |
| CCDC30 | C1orf50 | Q9BV19 | 417 |
| CCDC30 | NAGPA | Q9UK23 | 408 |
| CCDC30 | FGFRL1 | Q8N441 | 398 |
| CCDC30 | TMEM190 | Q8WZ59 | 375 |
| CCDC30 | CCDC150 | Q8NCX0 | 374 |
| CCDC30 | CCAR1 | Q8IX12 | 371 |
| CCDC30 | ZNF497 | Q6ZNH5 | 371 |
| CCDC30 | RERE | Q9P2R6 | 371 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCDC30 | CCT6A | psi-mi:“MI:0915”(physical association) | 0.400 |
| BRAP | CCDC30 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (10): CCDC30 (Two-hybrid), CCDC30 (Synthetic Lethality), CCDC30 (Proximity Label-MS), CCDC30 (Affinity Capture-MS), CCDC30 (Affinity Capture-RNA), CCDC30 (Affinity Capture-RNA), CCDC30 (Proximity Label-MS), CCDC30 (Affinity Capture-MS), EEA1 (Cross-Linking-MS (XL-MS)), CCDC30 (Affinity Capture-RNA)
ESM2 similar proteins: A0A1W2P884, A0P8Z5, A2AM05, A2BGP7, A7E3D8, A8MT70, B0CM36, B1WC58, E9PVD1, O75410, O95447, Q1RMS0, Q2M243, Q3UPP8, Q3V036, Q4KMA0, Q4R3Q7, Q4R3X1, Q5PQS2, Q5R9L2, Q5U465, Q5U5Q9, Q5VVM6, Q5VX52, Q5XI03, Q66KC9, Q6NRH3, Q6NZK5, Q6P9F0, Q6PJW8, Q6Y685, Q70YC5, Q7Z4H7, Q86T90, Q86Z20, Q8BFU3, Q8BG89, Q8BVF4, Q8CDM4, Q8IW35
Diamond homologs: Q5VVM6, Q8BVF4, Q8WP33
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
352 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 3 |
| Uncertain significance | 202 |
| Likely benign | 113 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (5)
| Variant ID | HGVS | Classification |
|---|---|---|
| 590783 | NM_024664.4(PPCS):c.538G>C (p.Ala180Pro) | Pathogenic |
| 59966 | GRCh38/hg38 1p34.2-34.1(chr1:40462415-44668040)x1 | Pathogenic |
| 1679771 | NM_001287511.2(PPCS):c.636_639del (p.Leu213fs) | Likely pathogenic |
| 242842 | GRCh37/hg19 1p34.2(chr1:41343608-43121507)x1 | Likely pathogenic |
| 3767229 | NM_024664.4(PPCS):c.727G>C (p.Ala243Pro) | Likely pathogenic |
SpliceAI
3748 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:42490153:TTTA:T | acceptor_loss | 1.0000 |
| 1:42490154:TTAG:T | acceptor_loss | 1.0000 |
| 1:42490156:A:AG | acceptor_gain | 1.0000 |
| 1:42490156:A:G | acceptor_loss | 1.0000 |
| 1:42490157:G:GT | acceptor_gain | 1.0000 |
| 1:42490157:GATTC:G | acceptor_gain | 1.0000 |
| 1:42490229:GGT:G | donor_loss | 1.0000 |
| 1:42490230:G:GG | donor_gain | 1.0000 |
| 1:42490230:GT:G | donor_loss | 1.0000 |
| 1:42490231:T:A | donor_loss | 1.0000 |
| 1:42497090:T:TA | acceptor_gain | 1.0000 |
| 1:42497096:A:AG | acceptor_gain | 1.0000 |
| 1:42497096:A:AT | acceptor_loss | 1.0000 |
| 1:42497096:AGAT:A | acceptor_gain | 1.0000 |
| 1:42497097:G:GA | acceptor_gain | 1.0000 |
| 1:42497097:GA:G | acceptor_gain | 1.0000 |
| 1:42497097:GAT:G | acceptor_gain | 1.0000 |
| 1:42497097:GATG:G | acceptor_gain | 1.0000 |
| 1:42497097:GATGC:G | acceptor_gain | 1.0000 |
| 1:42497209:AAATG:A | donor_gain | 1.0000 |
| 1:42497210:AATG:A | donor_gain | 1.0000 |
| 1:42497211:ATG:A | donor_gain | 1.0000 |
| 1:42497212:TG:T | donor_gain | 1.0000 |
| 1:42497212:TGG:T | donor_loss | 1.0000 |
| 1:42497213:GG:G | donor_gain | 1.0000 |
| 1:42497214:G:A | donor_loss | 1.0000 |
| 1:42497214:G:GG | donor_gain | 1.0000 |
| 1:42498814:TAA:T | acceptor_loss | 1.0000 |
| 1:42498816:A:AT | acceptor_loss | 1.0000 |
| 1:42498816:A:G | acceptor_gain | 1.0000 |
AlphaMissense
6258 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:42637317:G:C | R526P | 0.991 |
| 1:42642537:T:C | L568P | 0.981 |
| 1:42642516:T:C | L561P | 0.980 |
| 1:42644746:T:C | L610P | 0.973 |
| 1:42577033:T:C | L290P | 0.970 |
| 1:42566405:T:C | L262P | 0.968 |
| 1:42566417:G:C | R266P | 0.962 |
| 1:42566456:T:C | L279P | 0.959 |
| 1:42581370:T:C | L359P | 0.956 |
| 1:42577041:G:C | A293P | 0.953 |
| 1:42577218:G:C | A352P | 0.953 |
| 1:42644725:T:C | L603S | 0.948 |
| 1:42611075:T:C | L494P | 0.946 |
| 1:42637275:T:C | L512P | 0.945 |
| 1:42539198:T:C | L48P | 0.942 |
| 1:42642504:A:C | Q557P | 0.941 |
| 1:42577126:T:C | L321P | 0.940 |
| 1:42637359:T:C | L540P | 0.938 |
| 1:42644767:T:C | L617S | 0.933 |
| 1:42581459:G:C | A389P | 0.931 |
| 1:42644773:G:C | R619P | 0.928 |
| 1:42611042:T:C | L483P | 0.925 |
| 1:42566369:G:C | R250P | 0.924 |
| 1:42642500:G:C | A556P | 0.919 |
| 1:42566392:G:C | A258P | 0.916 |
| 1:42637293:G:C | R518P | 0.915 |
| 1:42637329:T:C | I530T | 0.913 |
| 1:42642558:A:C | Q575P | 0.913 |
| 1:42642546:A:C | Q571P | 0.909 |
| 1:42611021:T:C | L476P | 0.908 |
dbSNP variants (sampled 300 via entrez): RS1000014577 (1:42460994 G>A,T), RS1000018078 (1:42480868 C>T), RS1000075223 (1:42489097 C>T), RS1000087683 (1:42527089 G>A), RS1000140972 (1:42479029 C>G), RS1000142128 (1:42550729 G>A,T), RS1000144769 (1:42615411 C>G), RS1000154209 (1:42620181 C>A), RS1000162877 (1:42639861 G>A), RS1000165879 (1:42620468 G>T), RS1000169802 (1:42500705 G>T), RS1000199902 (1:42568675 G>A), RS1000217144 (1:42613937 G>C,T), RS1000243232 (1:42523926 C>A), RS1000283476 (1:42468105 A>C)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:618189, MIM:603896
GenCC curated gene-disease
Mondo (2): cardiomyopathy, dilated, 2c (MONDO:0032592), leukoencephalopathy with vanishing white matter 1 (MONDO:0020507)
Orphanet (1): Cree leukoencephalopathy (Orphanet:99854)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006629_47 | Pulse pressure | 9.000000e-16 |
| GCST007267_179 | Systolic blood pressure | 2.000000e-09 |
| GCST007269_21 | Pulse pressure | 6.000000e-12 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
| EFO:0006335 | systolic blood pressure |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, decreases methylation, increases methylation | 4 |
| sodium arsenite | affects expression, increases expression | 2 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| bisphenol S | affects cotreatment, increases methylation | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | increases expression, affects cotreatment, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | increases expression, increases abundance | 1 |
| Theophylline | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cardiomyopathy, dilated, 2c, leukoencephalopathy with vanishing white matter 1